| INCYTE DL-,001 |
| USA |
| Gesundheit |
| US45337C1027 / 896133 |
| ICY (Frankfurt) / INCY (NASDAQ) |
| FRA:ICY, ETR:ICY, ICY:GR, NASDAQ:INCY |
| S&P500 |
| https://incyte.com/ |
|
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates on hematology and oncology, as well as inflammati..
>Volltext.. |
| 19071.5 Mio. EUR |
| 15630.85 Mio. EUR |
| 4718.52 Mio. EUR |
| 1359.75 Mio. EUR |
| 1260.18 Mio. EUR |
| 6.42 EUR |
| 34.7 Mio. EUR |
| 3046.31 Mio. EUR |
| 1335 Mio. EUR |
| 2.7 |
| 13.75% |
| 6203.1% |
| - |
| - |
| - |
| INCYTE |
| 26.06.26 |
|
||||
|
||||
|
||||
|